Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”Attending the International Society on Thrombosis and Haemostasis (ISTH) Congress is always one of the highlights of my year ISTH 2026, and I was especially excited to be in Paris, France this year.
I had the privilege of presenting our latest work on ADAMTS13/VWF dysregulation in sepsis on behalf of my graduate student, Olamilekan George.
Throughout my career, ISTH has played a transformative role by fostering an exceptional global network of colleagues, hosting a vibrant and scientifically outstanding congress, championing diversity and inclusivity, and providing awards and opportunities that enable early-career investigators to participate and grow.
The Society has created an environment where scientists at every stage can connect, collaborate, and thrive, and I am grateful to be part of this remarkable community.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026